These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 371269)

  • 1. [E-antibodies in the sera of animals inoculated against plague and pseudotuberculosis].
    Orlov GS
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Oct; (10):123-4. PubMed ID: 371269
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
    Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenicity of B-antigen in experimental plague and pseudotuberculosis].
    Byvalov AA; Krupin VV; Gavrilov KE
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):49-53. PubMed ID: 16830590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study by immunoblotting of the serological response in white mice and guinea pigs inoculated against plague].
    Nekliaev VN; Gamleshko KhP; Rozhkov KK
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):75-6. PubMed ID: 8553775
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cross immunity to plague and tularemia].
    Vasenin AS; Veĭnblat VI; Samoĭlova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):49-52. PubMed ID: 7395403
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine.
    Bubeck SS; Dube PH
    Clin Vaccine Immunol; 2007 Sep; 14(9):1235-8. PubMed ID: 17652523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.
    Li B; Jiang L; Song Q; Yang J; Chen Z; Guo Z; Zhou D; Du Z; Song Y; Wang J; Wang H; Yu S; Wang J; Yang R
    Infect Immun; 2005 Jun; 73(6):3734-9. PubMed ID: 15908403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
    Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia pestis V protein epitopes recognized by CD4 T cells.
    Parent MA; Berggren KN; Mullarky IK; Szaba FM; Kummer LW; Adamovicz JJ; Smiley ST
    Infect Immun; 2005 Apr; 73(4):2197-204. PubMed ID: 15784563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
    DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O
    Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plague vaccines and the molecular basis of immunity against Yersinia pestis.
    Quenee LE; Schneewind O
    Hum Vaccin; 2009 Dec; 5(12):817-23. PubMed ID: 19786842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis).
    Rocke TE; Iams KP; Dawe S; Smith SR; Williamson JL; Heisey DM; Osorio JE
    Vaccine; 2009 Dec; 28(2):338-44. PubMed ID: 19879228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
    Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
    FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
    Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
    Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
    Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antibody spectrum after the inoculation of sensitive animals with Yersinia pestis and Yersinia pseudotuberculosis bacteria].
    Drobkov VI; Marakulin IV; Pogorel'skiĭ IP; Darmov IV; Smirnov EV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):81-5. PubMed ID: 8701667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.